Can-Fite BioPharma Ltd.
CANF · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $11,824 | $9,376 | $16,669 | $19,732 |
| - Cash | $4,825 | $4,278 | $2,978 | $4,390 |
| + Debt | $104 | $40 | $62 | $124 |
| Enterprise Value | $7,103 | $5,138 | $13,753 | $15,466 |
| Revenue | $674 | $743 | $810 | $853 |
| % Growth | -9.3% | -8.3% | -5% | – |
| Gross Profit | $674 | $743 | $810 | $853 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$8,123 | -$8,180 | -$10,082 | -$12,828 |
| % Margin | -1,205.2% | -1,100.9% | -1,244.7% | -1,503.9% |
| Net Income | -$7,880 | -$7,634 | -$10,173 | -$12,595 |
| % Margin | -1,169.1% | -1,027.5% | -1,255.9% | -1,476.6% |
| EPS Diluted | -1.08 | -1.8 | -3.75 | -8.25 |
| % Growth | 40% | 52% | 54.5% | – |
| Operating Cash Flow | -$7,637 | -$8,440 | -$10,801 | -$9,858 |
| Capital Expenditures | -$5 | -$2 | -$9 | -$11 |
| Free Cash Flow | -$7,642 | -$8,442 | -$10,810 | -$9,869 |